Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 03.09.2024
M1 Kliniken AG
Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024
Group: sales +11.2% to EUR 167.7 million and EBIT +98.8% to EUR 14.5 million
Earnings per share increased from EUR 0.17 to EUR 0.53
Beauty segment: sales +30.6% and EBIT +24.3%
Profitable growth to be continued
Berlin, 03.09.2024 – [ … ]
Tue, 03.09.2024
Aquis Stock Exchange
The following securities will be withdrawn from trading on the Aquis Stock Exchange Growth Market with effect from market open today, 3 September 2024:
St Mark Homes Plc
Ordinary shares
Symbol: SMAP
ISIN: GB0033501445
Aquis Stock Exchange
Floor 2, 63 Queen Victoria Street, EC4N 4UA
Tel: 0203 597 6361
Email: aqseregulation@aquis.eu
W [ … ]
Tue, 03.09.2024
Busha
Busha invites forward-thinking companies to explore how this development can enhance their cross-border activities and operations in African markets
Busha (www.Busha.ng), a leading cryptocurrency exchange platform, has been granted one of the first provisional licenses by the Nigerian Securities and Exchange Commission (SEC) to operate as a regula [ … ]
Tue, 03.09.2024
QIAGEN N.V.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. NOT FOR DISTRIBUTION TO ANY U.S. PERSON. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.
Ad-hoc announcement p [ … ]
Tue, 03.09.2024
Dexus Finance Pty Limited
Dexus (ASX: DXS)
ASX release3 September 2024
Appendix 3Y - Change of Director’s Interest Notice
Dexus today announced an Appendix 3Y - Change of Director’s Interest Notice
The full announcement is available at https://www.dexus.com/investor-centre/listed-funds/dexus-dxs/asx-announcementAuthorised by Brett Cameron, General Counsel and Company Secret [ … ]
Tue, 03.09.2024
Evotec SE
Dr Matthias Evers steps down as Chief Business Officer effective 01 October 2024
Distribution of responsibilities across other Management Board functions
Hamburg, Germany, 03 September 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Business Officer, [ … ]
Tue, 03.09.2024
Leonteq AG
Leonteq AG
/ Key word(s): Alliance
Leonteq launches cooperation with Saxo Bank
03.09.2024 / 07:00 CET/CEST
PRESS RELEASE | LEONTEQ LAUNCHES COOPERATION WITH SAXO BANK
Zurich, 03 September 2024
Leonteq announced today that it has initiated a new cooperation with Saxo Bank A/S for the manufacturing and distributio [ … ]
Tue, 03.09.2024
Swiss Life Holding AG
Zurich, 3 September 2024
Ad hoc announcement pursuant to Art. 53 LR
Adjusted profit from operations: up 7% to CHF 883 million (HY 23: CHF 828 million); net profit: CHF 632 million (HY 23: CHF 630 million)
Fee result: CHF 395 million (+17%)
Return on equity: 17.8% (HY 23: 15.8%)
Cash remittance to the holding company: CHF 1.26 billion (+19%)
S [ … ]
Tue, 03.09.2024
AEVIS VICTORIA SA
AEVIS VICTORIA SA
/ Key word(s): Miscellaneous
AEVIS VICTORIA SA (AEVS.SW) – Klinik Pyramide to be integrated into Privatklinik Bethanien in Zurich
03.09.2024 / 07:00 CET/CEST
Press Release
Fribourg, 3 September 2024
AEVIS VICTORIA SA (AEVS.SW) – Klinik Pyramide to be integrated into Privatklinik Bethanien in Zurich [ … ]
Tue, 03.09.2024
Xlife Sciences AG
Zurich, 3rd of September 2024: Xlife Sciences AG (SIX: XLS) today announced that the Board of Directors has completed the strategic review and, as of September 2, 2024, has tasked management with implementing the process. The shareholders will be informed of the next steps by September 30, 2024, at the latest.
The size and diversity of the portfoli [ … ]